Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Boehringer Ingelheim
Express Scripts
Merck
Colorcon
Chubb
Chinese Patent Office
Teva
McKesson
US Army
AstraZeneca

Generated: August 22, 2017

DrugPatentWatch Database Preview

BLEPH-10 Drug Profile

« Back to Dashboard

What is the patent landscape for Bleph-10, and when can generic versions of Bleph-10 launch?

Bleph-10 is a drug marketed by Allergan and is included in two NDAs.

The generic ingredient in BLEPH-10 is sulfacetamide sodium. There are three drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the sulfacetamide sodium profile page.

Summary for Tradename: BLEPH-10

Patents:0
Applicants:1
NDAs:2
Suppliers / Packagers: see list2
Bulk Api Vendors: see list59
Patent Applications: see list3,189
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:BLEPH-10 at DailyMed

Pharmacology for Tradename: BLEPH-10

Ingredient-typeSulfonamides
Drug ClassSulfonamide Antibacterial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Allergan
BLEPH-10
sulfacetamide sodium
OINTMENT;OPHTHALMIC084015-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Allergan
BLEPH-10
sulfacetamide sodium
SOLUTION/DROPS;OPHTHALMIC080028-001Approved Prior to Jan 1, 1982ATRXNoYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

McKesson
Mallinckrodt
Julphar
QuintilesIMS
Harvard Business School
Merck
Queensland Health
Healthtrust
AstraZeneca
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot